T-cell transcriptome analysis points up a thymic disorder in idiopathic nephrotic syndrome

Kidney International

Volumn 67, Issue 6, 2005, Pages 2168-2177

  Mansour, Hicham ^b   Cheval, Lydie ^b   Elalouf, Jean Marc ^b   Aude, Jean Christophe ^b   Alyanakian, Maria Alexandra ^b   Mougenot, Béatrice ^b   Doucet, Alain ^a   Deschênes, Georges ^b  

^a CENTRE DE RECHERCHE DES CORDELIERS   (France)

^b NONE

Author keywords

Apoptosis; L selectin; NF B; Selection; Steroid sensitive nephrotic syndrome; T cell differentiation protein

Indexed keywords

CD2 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; L SELECTIN; PREDNISOLONE; PROTEIN; PROTEIN T LYMPHOCYTE MATURATION ASSOCIATED PROTEIN; UNCLASSIFIED DRUG; MESSENGER RNA;

ARTICLE; CELL DIFFERENTIATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; MALE; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROTEINURIA; RELAPSE; REMISSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERIAL ANALYSIS OF GENE EXPRESSION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; THYMUS DISEASE; TRANSCRIPTOMICS; GENE EXPRESSION PROFILING; GENETICS; GLOMERULUS; LYMPHOCYTE ACTIVATION; METABOLISM; PRESCHOOL CHILD; RECURRENT DISEASE; THYMUS;

ANTIGENS, CD2; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION PROFILING; HUMANS; KIDNEY GLOMERULUS; L-SELECTIN; LYMPHOCYTE ACTIVATION; MALE; NEPHROTIC SYNDROME; PROTEINURIA; RECURRENCE; RNA, MESSENGER; T-LYMPHOCYTES; THYMUS GLAND;

EID: 23044444302     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00322.x     Document Type: Article

References (60)

1. BROYER M, MEYRIER A, NIAUDET P, HABIB R: Minima changes and focal segmental glomerular sclerosis, in Oxford Textbook of Clinical Nephrology (vol 1), edited by Davison A, Cameron J, Grünfeld J, Kerr D, Ritz E, CG W, Oxford, Oxford University Press, 1998, pp 493-535
2. TOPALOGLU R, SAATCI U, ARIKAN M, et al: T-cell subsets, interleukin-2 receptor expression and production of interleukin-2 in minimal change nephrotic syndrome. Pediatr Nephrol 8:649-652, 1994
3. DANIEL V, TRAUTMANN Y, KONRAD M, et al: T-lymphocyte populations, cytokines and other growth factors in serum and urine of children with idiopathic nephrotic syndrome. Clin Nephrol 47:289-297, 1997
4. LAMA G, LUONGO I, TIRINO G, et al: T-lymphocyte populations and cytokines in childhood nephrotic syndrome. Am J Kidney Dis 39:958-965, 2002
5. YAP HK, CHEUNG W, MURUGASU B, et al: Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome: Evidence for increased IL-13 mRNA expression in relapse. J Am Soc Nephrol 10:529-537, 1999
6. STACHOWSKI J, BARTH C, MICHALKIEWICZ J, et al: Th1/Th2 balance and CD45-positive T cell subsets in primary nephrotic syndrome. Pediatr Nephrol 14:779-785, 2000
7. ZACHWIEJA J, BOBKOWSKI W, DOBROWOLSKA-ZACHWIEJA A, et al: Intracellular cytokines of peripheral blood lymphocytes in nephrotic syndrome. Pediatr Nephrol 17:733-740, 2002
8. KANEKO K, TUCHIYA K, FUJINAGA S, et al: Th1/Th2 balance in childhood idiopathic nephrotic syndrome. Clin Nephrol 58:393-397, 2002
9. GRIMBERT P, VALANCIUTE A, AUDARD V, et al: Truncation of C-mip (Tc-mip), a new proximal signaling protein, induces c-maf Th2 transcription factor and cytoskeleton reorganization. J Exp Med 198:797-807, 2003
10. MATSUMOTO K, KANMATSUSE K: Increased IL-12 release by monocytes in nephrotic patients. Clin Exp Immunol 117:361-367, 1999
11. LAGRUE G, BRANELLEC A, BLANC C, et al: A vascular permeability factor in lymphocyte culture supernants from patients with nephrotic syndrome. II. Pharmacological and physicochemical properties. Biomedicine 23:73-75, 1975
12. LEVIN M, GASCOINE P, TURNER MW, BARRATT TM: A highly cationic protein in plasma and urine of children with steroid-responsive nephrotic syndrome. Kidney Int 36:867-877, 1989
13. TANAKA R, YOSHIKAWA N, NAKAMURA H, ITO H: Infusion of peripheral blood mononuclear cell products from nephrotic children increases albuminuria in rats. Nephron 60:35-41, 1992
14. GIRARDIN EP, BIRMELE B, BENADOR N, et al: Effect of plasma from patients with idiopathic nephrotic syndrome on proteoglycan synthesis by human and rat glomerular cells. Pediatr Res 43:489-495, 1998
15. KOYAMA A, FUJISAKI M, KOBAYASHI M, et al: A glomerular permeability factor produced by human T cell hybridomas. Kidney Int 40:453-460, 1991
16. DANTAL J, BAATARD R, HOURMANT M, et al: Recurrent nephrotic syndrome following renal transplantation in patients with focal glomerulosclerosis. A one-center study of plasma exchange effects. Transplantation 52:827-831, 1991
17. LE BERRE L, GODFRIN Y, LAFOND-PUYET L, et al: Effect of plasma fractions from patients with focal and segmental glomerulosclerosis on rat proteinuria. Kidney Int 58:2502-2511, 2000
18. SAHALI D, PAWLAK A, VALANCIUTE A, et al: A novel approach to investigation of the pathogenesis of active minimal-change nephrotic syndrome using subtracted cDNA library screening. J Am Soc Nephrol 13:1238-1247, 2002
19. SAVIN VJ, SHARMA R, SHARMA M, et al: Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 334:878-883, 1996
20. MUSANTE L, CANDIANO G, BRUSCHI M, et al: Characterization of plasma factors that alter the permeability to albumin within isolated glomeruli. Proteomics 2:197-205, 2002
21. VELCULESCU VE, ZHANG L, VOGELSTEIN B, KINZLER KW: Serial analysis of gene expression. Science 270:484-487, 1995
22. VIRLON B, CHEVAL L, BUHLER JM, et al: Serial microanalysis of renal transcriptomes. Proc Natl Acad Sci USA 96:15286-15291, 1999
23. ELALOUF JM, BUHLER JM, TESSIOT C, et al: Predominant expression of beta 1-adrenergic receptor in the thick ascending limb of rat kidney. Absolute mRNA quantitation by reverse transcription and polymerase chain reaction. J Clin Invest 91:264-272, 1993
24. VELCULESCU VE, ZHANG L, ZHOU W, et al: Characterization of the yeast transcriptome. Cell 88:243-251, 1997
25. WALCHECK B, ALEXANDER SR, ST HILL CA, MATALA E: ADAM-17-independent shedding of L-selectin. J Leukoc Biol 74:389-394, 2003
26. SAMSTAG Y, EIBERT SM, KLEMKE M, WABNITZ GH: Actin cytoskeletal dynamics in T lymphocyte activation and migration. J Leukoc Biol 73:30-48, 2003
27. PERRY SS, WANG H, PIERCE LJ, et al: L-selectin defines a bone marrow analog to the thymic early T-lineage progenitor. Blood 103:2990-2996, 2004
28. LEPIQUE AP, PALENCIA S, IRJALA H, PETRIE HT: Characterization of vascular adhesion molecules that may facilitate progenitor homing in the post-natal mouse thymus. Clin Dev Immunol 10:27-33, 2003
29. LUETTIG B, SPONHOLZ A, HEERWAGEN C, et al: Recent thymic emigrants (CD4+) continuously migrate through lymphoid organs: Within the tissue they alter surface molecule expression. Scand J Immunol 53:563-571, 2001
30. ALONSO MA, WEISSMAN SM: cDNA cloning and sequence of MAL, a hydrophobic protein associated with human T-cell differentiation. Proc Natl Acad Sci USA 84:1997-2001, 1987
31. COPIE-BERGMAN C, PLONQUET A, ALONSO MA, et al: MAL expression in lymphoid cells: Further evidence for MAL as a distinct molecular marker of primary mediastinal large B-cell lymphomas. Mod Pathol 15:1172-1180, 2002
32. SAHALI D, PAWLAK A, LE GOUVELLO S, et al: Transcriptional and post-transcriptional alterations of IkappaBalpha in active minimal-change nephrotic syndrome. J Am Soc Nephrol 12:1648-1658, 2001
33. ESSLINGER CW, JONGENEEL CV, MACDONALD HR: Survival-independent function of NF-kappaB/Rel during late stages of thymocyte differentiation. Mol Immunol 35:847-852, 1998
34. HETTMANN T, DIDONATO J, KARIN M, LEIDEN JM: An essential role for nuclear factor kappaB in promoting double positive thymocyte apoptosis. J Exp Med 189:145-158, 1999
35. SENFTLEBEN U, LI ZW, BAUD V, KARIN M: IKKbeta is essential for protecting T cells from TNFalpha-induced apoptosis. Immunity 14:217-230, 2001
36. ZHU JW, DERYCKERE D, LI FX, et al: A role for E2F1 in the induction of ARF, p53, and apoptosis during thymic negative selection. Cell Growth Differ 10:829-838, 1999
37. CHOW SC, SNOWDEN R, ORRENIUS S, COHEN GM: Susceptibility of different subsets of immature thymocytes to apoptosis. FEBS Lett 408:141-146, 1997
38. HAN S, CHOI H, KO MG, et al: Peripheral T cells become sensitive to glucocorticoid- and stress-induced apoptosis in transgenic mice overexpressing SRG3. J Immunol 167:805-810, 2001
39. LOC NK, OLAH I, TAKACS L, et al: Effect of cyclophosphamide on the rat thymus. Acta Morphol Acad Sci Hung 29:319-333, 1981
40. EHRICH JH, BRODEHL J: Long versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Arbeitsgemeinschaft fur Padiatrische Nephrologie. Eur J Pediatr 152:357-361, 1993
41. UEDA N, KUNO K, ITO S: Eight and 12 week courses of cyclophosphamide in nephrotic syndrome. Arch Dis Child 65:1147-1150, 1990
42. AUWAERTER PG, KANESHIMA H, MCCUNE JM, et al: Measles virus infection of thymic epithelium in the SCID-hu mouse leads to thymocyte apoptosis. J Virol 70:3734-3740, 1996
43. SHALHOUB RJ: Pathogenesis of lipoid nephrosis: A disorder of T-cell function. Lancet 2:556-560, 1974
44. DAMOISEAUX JG, DEFRESNE MP, REUTELINGSPERGER CP, VAN BREDA VRIESMAN PJ: Cyclosporin-A differentially affects apoptosis during in vivo rat thymocyte maturation. Scand J Immunol 56:353-360, 2002
45. NIAUDET P: Comparison of cyclosporin and chlorambucil in the treatment of steroid-dependent idiopathic nephrotic syndrome: A multicentre randomized controlled trial. The French Society of Paediatric Nephrology. Pediatr Nephrol 6:1-3, 1992
46. FAKHOURI F, BOCQUET N, TAUPIN P, et al: Steroid-sensitive nephrotic syndrome: From childhood to adulthood. Am J Kidney Dis 41:550-557, 2003
47. STEINMANN GG, KLAUS B, MULLER-HERMELINK HK: The involution of the ageing human thymic epithelium is independent of puberty. A morphometric study. Scand J Immunol 22:563-575, 1985
48. WAHL SM, ORENSTEIN JM, CHEN W: TGF-beta influences the life and death decisions of T lymphocytes. Cytokine Growth Factor Rev 11:71-79, 2000
49. MICHALLET MC, SALTEL F, PREVILLE X, et al: Cathepsin-B-dependent apoptosis triggered by antithymocyte globulins: A novel mechanism of T-cell depletion. Blood 102:3719-3726, 2003
50. RAAFAT R, TRAVIS LB, KALIA A, DIVEN S: Role of transplant induction therapy on recurrence rate of focal segmental glomerulosclerosis. Pediatr Nephrol 14:189-194, 2000
51. NAL B, CARROLL P, MOHR E, et al: Coronin-1 expression in T lymphocytes: Insights into protein function during T cell development and activation. Int Immunol 16:231-240, 2004
52. DELGADO P, FERNANDEZ E, DAVE V, et al: CD3delta couples T-cell receptor signalling to ERK activation and thymocyte positive selection. Nature 406:426-430, 2000
53. GERNER C, FROHWEIN U, GOTZMANN J, et al: The Fas-induced apoptosis analyzed by high throughput proteome analysis. J Biol Chem 275:39018-39026, 2000
54. RUF RG, FUCHSHUBER A, KARLE SM, et al: Identification of the first gene locus (SSNS1) for steroid-sensitive nephrotic syndrome on chromosome 2p. J Am Soc Nephrol 14:1897-1900, 2003
55. KERN PM, KEILHOLZ L, KALDEN JR, HERRMANN M: Apoptotic UV-irradiated lymphocytes undergo protease mediated shedding of L-selectin in vitro. Transfus Apheresis Sci 24:99-101, 2001
56. LAWRENCE MB: Selectin-carbohydrate interactions in shear flow. Curr Opin Chem Biol 3:659-664, 1999
57. TAKEDA T, MCQUISTAN T, ORLANDO RA, FARQUHAR MG: Loss of glomerular foot processes is associated with uncoupling of podocalyxin from the actin cytoskeleton. J Clin Invest 108:289-301, 2001
58. DOYONNAS R, KERSHAW DB, DUHME C, et al: Anuria, omphalocele, and perinatal lethality in mice lacking the CD34-related protein podocalyxin. J Exp Med 194:13-27, 2001
59. STORDEUR P, ZHOU L, GOLDMAN M: Analysis of spontaneous mRNA cytokine production in peripheral blood. J Immunol Methods 261:195-197, 2002
60. CLARKE L, CARBON J: A colony bank containing synthetic Col El hybrid plasmids representative of the entire E. coli genome. Cell 9:91-99, 1976